Home Crystal structure of (2E,4Z)-dimethyl 4-((phenylamino)methylene)pent-2-enedioate, C14H15N1O4
Article Open Access

Crystal structure of (2E,4Z)-dimethyl 4-((phenylamino)methylene)pent-2-enedioate, C14H15N1O4

  • Xiao-Ming Chen , Xing-Yu Zhang EMAIL logo , Fu-Lin He , Jun Pan and Guo-Kai Jia
Published/Copyright: October 6, 2018

Abstract

C14H15N1O4, triclinic, P1̄, a = 8.2018(4) Å, b = 11.5512(5) Å, c = 14.4121(7) Å, α = 79.242(2)°, β = 78.647(3)°, γ = 85.496(3)°, V = 1313.93(11) Å3, Z = 2, Rgt(F) = 0.0548, wRref(F2) = 0.1805, T = 296(2) K.

CCDC no.: 1865985

The asymmetric unit of the title crystal structure is shown in the figure. Tables 1 and 2 contain details on crystal structure and measurement conditions and a list of the atoms including atomic coordinates and displacement parameters.

Table 1:

Data collection and handling.

Crystal:Colorless block
Size:0.26 × 0.24 × 0.18 mm
Wavelength:Mo Kα radiation (0.71073 Å)
μ:0.10 mm−1
Diffractometer, scan mode:Bruker APEX-II, φ and ω
θmax, completeness:27.6°, 99%
N(hkl)measured, N(hkl)unique, Rint:20977, 5899, 0.017
Criterion for Iobs, N(hkl)gt:Iobs > 2 σ(Iobs), 3894
N(param)refined:347
Programs:Bruker APEX system [1], SHELX [2, 3]
Table 2:

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2).

AtomxyzUiso*/Ueq
O70.82537(15)0.62219(10)0.75870(8)0.0605(3)
O30.83969(15)0.43118(10)0.46707(9)0.0607(3)
O40.71137(16)0.42066(10)0.61983(9)0.0638(3)
O50.80262(16)0.91956(10)0.50978(8)0.0632(4)
O60.64784(17)1.08640(10)0.51680(8)0.0691(4)
O10.77740(18)0.70625(10)0.20914(8)0.0703(4)
O80.71188(16)0.61463(11)0.91433(9)0.0684(4)
O20.68179(19)0.89080(10)0.21902(9)0.0745(4)
N10.49067(16)0.59313(10)0.66189(9)0.0503(3)
H10.5399240.5272020.6815470.060*
N20.49905(17)0.79047(11)0.95934(9)0.0540(4)
H20.5465810.7236850.9786040.065*
C180.69641(19)0.84022(12)0.70105(10)0.0451(3)
H180.7752110.7995460.6618770.054*
C80.53875(19)0.63916(12)0.56918(11)0.0457(4)
H80.4902130.7118000.5466110.055*
C60.73413(19)0.47397(13)0.53767(11)0.0481(4)
C50.65401(19)0.58790(12)0.50454(11)0.0452(4)
C220.54497(19)0.83624(13)0.86660(10)0.0476(4)
H220.4981560.9098190.8448250.057*
C190.65539(19)0.78393(13)0.80070(11)0.0463(4)
C200.7313(2)0.66769(13)0.83123(11)0.0495(4)
C90.3710(2)0.63771(13)0.73128(11)0.0469(4)
C40.69484(19)0.64128(12)0.40386(11)0.0475(4)
H40.7632200.5950240.3643600.057*
C160.6924(2)0.99066(13)0.55655(11)0.0484(4)
C230.3829(2)0.83753(13)1.02953(11)0.0486(4)
C20.7012(2)0.79044(14)0.25783(11)0.0525(4)
C170.6367(2)0.94246(13)0.65769(11)0.0524(4)
H170.5554120.9850210.6938590.063*
C280.2854(2)0.93922(15)1.00824(12)0.0610(5)
H280.2941660.9792220.9452840.073*
C100.3468(2)0.57444(15)0.82455(12)0.0585(4)
H100.4079620.5041720.8382820.070*
C140.2781(2)0.74213(15)0.71127(12)0.0589(4)
H140.2919180.7855250.6492450.071*
C240.3650(3)0.77924(16)1.12374(13)0.0654(5)
H240.4289380.7105301.1383850.078*
C30.6484(2)0.74683(14)0.36010(11)0.0556(4)
H30.5784550.7954880.3967420.067*
C110.2339(3)0.61424(16)0.89659(12)0.0671(5)
H110.2193120.5712630.9587730.080*
C130.1650(3)0.78041(17)0.78491(13)0.0709(5)
H130.1028760.8503760.7717010.085*
C270.1756(3)0.98000(16)1.08157(13)0.0704(5)
H270.1105351.0482711.0675120.085*
C150.8677(3)0.96535(17)0.41106(12)0.0709(5)
H15A0.7779040.9830050.3761270.106*
H15B0.9437980.9077340.3838880.106*
H15C0.9250051.0359720.4070320.106*
C120.1417(3)0.71829(18)0.87677(13)0.0714(5)
H120.0648000.7457040.9253000.086*
C210.9084(3)0.50944(16)0.78300(15)0.0726(5)
H21A0.9708250.4854150.7255280.109*
H21B0.8273580.4521710.8140810.109*
H21C0.9825790.5154460.8256260.109*
C70.9226(2)0.31916(15)0.49457(15)0.0702(5)
H7A0.9954940.2970710.4393100.105*
H7B0.8412640.2604470.5202030.105*
H7C0.9862180.3252300.5425480.105*
C10.8426(3)0.74309(18)0.10951(12)0.0754(6)
H1A0.8753290.6750290.0797480.113*
H1B0.9376470.7896870.1025140.113*
H1C0.7588780.7893660.0792230.113*
C260.1600(3)0.92208(17)1.17525(13)0.0720(5)
H260.0858240.9513111.2239520.086*
C250.2547(3)0.82105(18)1.19600(12)0.0725(5)
H250.2442440.7807781.2589430.087*

Source of material

Methyl propiolate (0.4203 g, 5.0 mmol), aniline (0.1863 g, 2.0 mmol), water (4 mL) and potassium sulfate (15.0 mg) were heated and stirred at 353 K for ten hours, then dichloromethane (15 mL) was added and the reaction mixture was poured into a separator funnel. The reaction mixture was concentrated by removing the solvent under vacuum, and the residue was purified by preparative TLC on silica, eluting with petroleum ether (333–363 K) : ethyl acetate (6:1,v/v) to give colourless block asymmetric unit of the title.

Experimental details

The non-methyl hydrogen atoms were identified in difference Fourier syntheses, but included using a riding model Uiso(H) = 1.2 Ueq(C). The methyl groups were idealized and refined using rigid groups allowed to rotate about the C—C bond (AFIX 137 option of the SHELXL-2015 program). There are two crystallogaphically independent molecules in the asymmetric unit. They show non-crystallographic (pseudo) translational symmetry. This phenomenon is known for small molecule structures as well as for biological systems [4] and my be checked by automated procedures [5].

Comment

Enyne compounds are not only important raw materials and intermediates in the organic synthesis, but also they are important building blocks for some anticancer drugs and antibiotics [6, 7] . The compounds having a conjugated alkenyl structure is known to have the strongest anticancer antibacterial activity at present [8, 9] . The synthesis and screening of reagents with high anticancer activity and stable low toxicity have become a research hotspot in chemistry, pharmacology, and molecular biology, especially the construction method of the conjugated alkyne structure of its core skeleton [10, 11] . Hence, there is considerable interest in the development of effective methods for the synthesis of it and its analogues [12, 13] .

However, the crystal structure of (2E,4Z)-dimethyl 4-((phenylamino)methylene)pent-2-enedioate has not been reported before. The title compound, built up by the C14H15N1O4 molecules, has been synthesized. The single-crystal structure verifies that all bond lengths and angles are in normal ranges.

The E, Z constitution was verified (cf. the figure).

Acknowledgements

The work was supported by the opening project of key laboratory of comprehensive utilization of advantage plants resources in Hunan south, Hunan university of science and engineering (XNZW17C07); The Planned Science and Technology Project of Hunan Province, China (NO. 2016GK3080) The project Study on New Drugs of Silybin Sustained-release Tablets (NO. 2017SK2204)

References

1. Bruker, SAINT, APEX and SADABS, Bruker Inc. Madison, WI, USA (2008).Search in Google Scholar

2. Sheldrick, G. M.: A short history of SHELX. Acta Crystallogr. A64 (2008) 112–122.10.1107/S0108767307043930Search in Google Scholar

3. Sheldrick, G. M.: SHELXT-integrated space-group and crystal-structure determination. Acta Crystallogr. C71 (2015) 3–8.10.1107/S2053273314026370Search in Google Scholar

4. Zwart, P. H.; Grosse-Kunstleve, R. W.; Lebedev, A. A.; Murshudov, G. N.; Adams, P. D.: Surprises and pitfalls arising from (pseudo)symmetry. Acta Crystallogr. D 64 (2008) 99–107.10.1107/S090744490705531XSearch in Google Scholar

5. Spek, A. L.: What makes a crystal structure report valid? Inorg. Chim. Acta 470 (2018) 232–237.10.1016/j.ica.2017.04.036Search in Google Scholar

6. Nishiura, M.; Hou, Z. M.; Wakatauki, Y.: Novel Z-selective head-to-head dimerization of terminal alkynes catalyzed by lanthanide half metalpcene complexes. J. Am. Chem. Soc. 5 (2003) 1184–1185.10.1021/ja027595dSearch in Google Scholar

7. Nicolaou, K. C.; Dai, W. M.; Tsay, S. C.: Palladium-catalyzed dimerization of terminal alkynes. Science 256 (1992) 1172–1178.10.1126/science.256.5060.1172Search in Google Scholar

8. Grissom, J. W.; Gunawardena, G. U.; Klingderg, D.: The chemistry enediynes, enyne allenes and related compound. Tetrahedron 52 (1996) 6453–6518.10.1016/0040-4020(96)00016-6Search in Google Scholar

9. Lee, M. D.; Dunne, T. S.; Siegel, M. M.: Calichemicins, a novel family of antitumor antibiotics. Chemistry and partial structure of calichemicing. J. Am. Chem. Soc. 11 (1987) 3464–3465.10.1021/ja00245a050Search in Google Scholar

10. Golik, J.; Dubay, G.: Esperamicins, a novel class of potent antitumor antibiotics. J. Am. Chem. Soc. 11 (1987) 3461–3463.10.1021/ja00245a048Search in Google Scholar

11. Zhang, S. L.; Deng, Z. Q.: Synthesis of quinolines and naphthyridines via catalytic retro-aldol reaction of β–hydroxyketones with ortho-aminobenzaldehydes or nicotinaldehydes. Org. Biomol. Chem. 14 (2016) 8966–8970.10.1039/C6OB01452FSearch in Google Scholar PubMed

12. Chatterjee, M.; Gramer, K. D.; Townsend, C. A.: Nature of thiol activation in DNA cleavage by cali cheamicin. J. Am. Chem. Soc. 8 (1993) 3374–3375.10.1021/ja00061a064Search in Google Scholar

13. Zhang, X. Y.; Yuan, L.; Zhang, M.; Yuan, X. Y.: Crystal structure of (2-(4-bromophenyl)-5-ethyl-1,3-dioxan-5-yl)methanol, C13H17O3Br. Z. Kristallogr. NCS 213 (2016) 961–963.10.1515/ncrs-2016-0022Search in Google Scholar

Received: 2018-06-03
Accepted: 2018-09-05
Published Online: 2018-10-06
Published in Print: 2018-12-19

©2018 Xiao-Ming Chen et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Articles in the same Issue

  1. Cover and Frontmatter
  2. Crystal structure of bis(6,6′-((ethane-1,2-diylbis(azanylylidene))bis(methanylylidene))bis(2,4-diiodophenolato)-κ4N,N′,O,O′)cer(IV), C32H20CeI8N4O4
  3. Crystal structure of (6,6′-((ethane-1,2-diylbis(azanylylidene))bis(methanylylidene))bis(2-chlorophenolato-κ2N,O))copper(II), C16H12Cl2CuN2O2
  4. Crystal structure of poly[aqua-(μ3-4-(pyridin-4-yl)isophthalato-κ4O,O′:O′′:O′′′)-(μ2-5-carboxy-2-(pyridin-4-yl)benzoato-κ2O:O′)samarium(III)], C26H18N2O9Sm
  5. Crystal structure of 1-{4-[(2-hydroxy-5-nitrobenzylidene)amino]phenyl}ethanone O-methyl oxime, C16H15N3O4
  6. Synthesis and crystal structure of bis(μ2-acetato-κ2O:O′)-bis(μ2-1-(8-(2-oxidophenyl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl)naphthalen-2-olato-κ6O:O,N,N′,O′:O′)trizinc(II), C44H38Zn3N4O12
  7. Synthesis and crystal structure of bis(μ2-acetato-κ2O:O′)–bis(μ2–(8-(2-oxidophenyl)-3,6-dioxa-2,7-diazaocta-1,7-dien-1-yl)naphthalen-2-olato-κ6O:O,N,N′,O′:O′)tricobalt(II), C44H38Co3N4O12
  8. Crystal structure of poly[aqua(μ4-2,2′,2′′-nitrilotriacetato-κ6O1,O3,O5:O2:O4:O6)-yttrium(III)], C6H8NO7Y
  9. Crystal structure of catena-poly[bromido-(μ2-pyrazine-2-carboxylato-κ3N:N′,O)copper(II)], C10H6N4Cu2O4Br
  10. Crystal structure of poly[dodekais(μ2-2,6-difluorobenzoato-κ2O:O′)-bis((μ3-hexamethylenetetramine-κ3N:N′:N′′)hexacopper(II)], C48H30N4O12F12Cu3
  11. Crystal structure of methyl 4-(4-hydroxy-3-nitrophenyl)-2-methyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C18H18N2O6
  12. Crystal structure of N-phenyl-2-(propan-2-ylidene)hydrazine-1-carbothioamide, C10H13N3S
  13. Crystal structure of sodium caesium zinc phosphate, NaCsZnP2O7
  14. Crystal structure of methyl 4-(4-isopropylphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydro-quinoline-3-carboxylate, C23H29NO3
  15. Crystal structure of catena-poly[bis(μ2-1,3-di(4H-1,2,4-triazol-4-yl)benzene-κ2N:N′)-bis(thiocyanato-κ1N)cobalt(II), C22H16CoN14S2
  16. Crystal structure of catena-poly[(μ2-2,5-di(pyridin-3-yl)-1,3,4-thiadiazole-κ2N:N′)-bis(2,5-di(pyridin-3-yl)-1,3,4-thiadiazole-κ1N)-bis(thiocyanato-κ1N)cobalt(II)], C38H24CoN14S5
  17. Crystal structure of bis(2,5-di(pyridin-2-yl)-1,3,4-thiadiazole-κ2N,N′)-bis(thiocyanato-κ1N)cobalt(II), C26H16CoN10S4
  18. Crystal structure of (bis((1H-benzo[d]imidazol2-yl)methyl)amine-κ3N,N′,N′′)-(pyridine-2,6-dicarboxylato-κ3N,O,O′)zinc(II) — methanol — water (1/2/1), C25H28N6O7Zn
  19. Crystal structure of catena-poly[triaqua-(μ2-5-methoxy-isophthalato-κ2O:O′)copper(II)], C9H12CuO8
  20. Structure and photochromism of 1-[2-methyl-5-phenyl-3-thienyl]-2-[2-methyl-5-(4-chlorophenyl)-3-thienyl]3,3,4,4,5,5-hexafluorocyclopent-1-ene, C27H16ClF6S2
  21. Crystal structure of methyl 4-(3-phenoxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate, C26H27NO4
  22. Crystal structure of poly[diaqua-di-μ2-hydroxido-(μ4-3,4,5,6-tetrafluoro-1,2-phthalato-κ4O:O′:O′′:O′′′)-(μ4-3,4,5,6-tetrafluoro-1,2-phthalato-κ5O,O:O′:O′′:O′′′)disamarium(III)] – bipyridine (2/1), C21H11NF16O12Sm2
  23. Crystal structural of diethyl 4-(3,5-dibromo-4-hydroxyphenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate, C19H21Br2NO5
  24. Crystal structure of catena-poly[tetraaqua(μ2-4-(1H-imidazol-1-yl)pyridine-κ2N:N′))zinc(II)] thiophene-2,5-dicarboxylate, C14H17N3O8ZnS
  25. Crystal structure of (20S)-20-(dimethylamino)-3-(tigloylamino)-5α-pregn-2,16-dien-4-one, C28H42N2O2
  26. Crystal structure of rac-trans-N,N′-bis(3,5-diiodosalicylidene)-1,2-cyclohexanediamine, C20H18I4N2O2
  27. Crystal structure of 2-bromo-7-(4-(dimethylamino)phenyl)-10-methylacridin-9 (10H)-one, C22H19BrN2O
  28. Crystal structure of catena-poly[(μ2-pentane-1,5-dicarboxylato-κ2O:O′)-(μ2-2-[(1H-imidazol-1-yl)methyl]-6-methyl-1H-benzimidazole-κ2N:N′)zinc(II)] sesquihydrate, C17H21N4O5.5Zn
  29. Crystal structure of ethyl 2-amino-4-(3,4-difluorophenyl)-5-oxo-4H,5H-pyrano[3,2-c] chromene-3-carboxylate, C21H15F2NO5
  30. Crystal structure of 9-(5-methylthiophen-2-yl)-3,4,5,6,7,9-hexahydro-1H-xanthene-1,8(2H)-dione, C18H18O3S
  31. Crystal structure of [5,5′-((propane-1,3-diylbis(azanylylidene))bis(ethan-1-yl-2-ylidene))bis(3-(ethoxycarbonyl)-2,4-dimethylpyrrol-1-ido)-κ4N,N′,N′′,N′′′]nickel(II), C23H30N4O4Ni
  32. Crystal structure of (Z)-2-(2-(1,3-dioxo-1-(phenylamino)butan-2-ylidene)hydrazineyl) terephthalic acid-dimethylsulfoxide (1/1), C18H15N3O6 ⋅ C2H6OS
  33. Crystal structure of (2E,4Z)-dimethyl 4-((phenylamino)methylene)pent-2-enedioate, C14H15N1O4
  34. Crystal structure of (2Z,2′Z)-1,1′-(pyridine-2,6-diyl) bis(3-hydroxy-3-phenylprop-2-en-1-one), C23H17NO4
  35. Crystal structure of ethyl 2-amino-4-(3-bromophenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carboxylate, C21H16BrNO5
  36. Crystal structure of bis(μ2-3,5-dichloro-2-oxidobenzoato-κ4O,O′:O′,O′′)-hexakis(μ2-pivalato-κ2O:O′)-bis(pivalato-κ2O,O′)-tetrakis(1,10-phenanthroline-κ2N,N′)tetragadolinium(III), C102H108Cl4Gd4N8O22
  37. Crystal structure of catena-poly[aqua-bis(formato-κ1O)-(μ2-1,1′-(oxybis(1,4-phenylene))-bis(1H-1,2,4-triazole)-κ2N:N′)copper(II)]hydrate, C18H16CuN6O6
  38. Crystal structure of 5-bromo-2-(naphthalen-6-yl)pyridine, C15H10BrN
  39. Crystal structure of N-(4-methoxybenzyl)pyridazin-3-amine- a rare Z′ = 4 structure, C12H13N3O
  40. Crystal structure of bis(perchlorato-κ1O)-bis(3,4,5-trimethoxy-N-(pyridin-2-yl)benzamide-κ2N,O)copper(II), C32H30Cl2CuN4O16
  41. Crystal structure of methyl 4-methyl-2,5-di(pyridin-4-yl)-1H-pyrrole-3-carboxylate monohydrate C17H15N3O2⋅H2O
  42. Crystal structure of dimethyl 5-(10-(methoxycarbonyl)anthracen-9-yl) isophthalate,C26H20O6
  43. Crystal structure of tert-butyl (R)-(1-(benzylamino)-3-methoxy-1-oxopropan-2-yl)carbamate, C16H24N2O4
  44. Crystal structure of aqua-bis(1,5-dimethyl-2-phenyl-4-(((E)-4-pyridylmethylene)amino)pyrazolidin-3-one-κN)-(nitrato-κO)-(nitrato-κ2O,O′)zinc(II), C34H34N10O9Zn
  45. Crystal structure of catena-poly[dichlorido-(μ2-1,5-dimethyl-2-phenyl-4-((pyridin-4-ylmethylene)amino)-1,2-dihydro-3H-pyrazol-3-one-κ2N:O)cobalt(II)] – methanol (1/1), C18H20Cl2CoN4O2
  46. Crystal structure of poly[diaqua-bis(μ2-1-(4-(1H-imidazol-1-yl)benzyl)-1H-1,2,4-triazole-κ2N:N′)manganese(II)]bis(2-carboxybenzoate) dihydrate, MnC40H40N10O12
  47. The crystal structure of 4-((3,4-dichlorobenzylidene)amino)-1,5-dimethyl-2-phenyl-1,2-dihydro-3H-pyrazol-3-one, C18H15Cl2N3O
  48. Crystal structure of bis(2-methoxy-6-((2-(pyrimidin-2-yl)hydrazono)methyl)phenolato-κ3N,N′,O)iron(III) perchlorate, C24H22N8O8ClFe
  49. The crystal structure of 2-[4-hydroxy-3-methoxyphenyl]-4,4,5,5-tetramethylimidazoline-3-oxide-1-oxyl, C14H19N2O4
  50. Crystal structure of diaqua-bis(3,3-dimethylacrylato-κ2O,O′)zinc(II), C10H18ZnO6
  51. Crystal structure of dichloro-tetrakis[(E)-1-(4-chlorophenyl)-4,4-dimethyl-2-(1H-1,2,4-triazol-1-yl)pent-1-en-3-ol-κN]cadmium (II), C60H74CdCl6N12O4
  52. Crystal structure of (20R)-20,25-epoxy-dammaran-3,12-dione, C30H48O3
  53. Crystal structure of (E)-3′,6′-bis(ethylamino)-2′,7′-dimethyl-2-((pyridin-2-ylmethylene)amino)spiro[isoindoline-1,9′-xanthen]-3-one, C32H31N5O2
  54. The crystal structure of 2-(4-fluorophenyl)-1,3,4-oxadiazole, C8H5FN2O
  55. Crystal structure of (2,2′-bipyridine-κ2N,N′)bis(tri(p-tolyl)phosphine-κP)copper(I) tetrafluoroborate – 4,4′-bipyridine (2/1), C57H54BCuF4N3P2
  56. The crystal structure of 2,6-dimethyl-3,5-dinitrocyclohexa-2,5-diene-1,4-dione, C8H6N2O6
  57. The crystal structure of 2,3-dimethyl-1,4-dinitrobenzene – a Z′ = 4 structure, C8H8N2O4
  58. Crystal structure of [(1,2-η)-1,2,3,4,5-pentamethyl-cyclopenta-2,4-dien-1-yl] (1,4,10,13-tetraoxa-7,16-diazacyclooctadecane-κ6N2,O4) rubidium (I), [Rb(diaza-18-crown-6)]Cp*, C22H41N2O4Rb
  59. Crystal structure of 2-(4-fluorophenyl)-N-phenyl-2-(phenylamino)ethanesulfonamide – toluene (1/0.5), C23.5H23FN2O2S
  60. Crystal structure of pyrene-4-aldehyde, C17H10O
  61. Crystal structure of 2-(furan-2-yl)-5-methyl-1,3-dioxane-5-carboxylic acid, C10H12O5
  62. Crystal structure of 2-(4-chlorophenyl)-3-phenyl-1,8-naphthyridine, C20H13N2Cl
  63. Crystal structure and photochromism of 1-(2-ethyl-5-formylthiophen-3yl)-2-(2-cyano-1,5-dimethyl-4-pyrrl)-3,3,4,4,5,5-hexafluorocyclopent-1-ene, C19H14F6N2OS
  64. Crystal structure of 2-(4-bromophenyl)-1,3-dimethyl-1H-perimidin-3-ium iodide, C19H16BrIN2
  65. Crystal structure of 2-(4-(dimethylamino)phenyl)-10-methylacridin-9(10H)-one, C22H20N2O
  66. Crystal structure of 4-(acetoxymethyl)-6-(3-acetyl-3-(4-fluorophenyl)thioureido)cyclohex-4-ene-1,2,3-triyl triacetate, C24H26FN2O9S
Downloaded on 21.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/ncrs-2018-0194/html
Scroll to top button